{{roughtranslation|time=2018-11-25T03:18:22+00:00}}
{{Infobox company
| name             = 英科智能
|native_name=Insilico Medicine
|native_lang=en
| logo             = 
| type             = [[私營企業|私營企業]]
| traded_as        = 
| genre            =
| fate             = 
| predecessor      = 
| successor        = 
| foundation       = {{Start date|2014|}}<ref name="a"/> 
| founder          = 阿歷克斯·查沃隆科夫（{{lang|en|Alex Zhavoronkov}}）
| defunct          = <!-- {{End date|YYYY|MM|DD}} -->
| location_city    = [[羅克維爾|羅克維爾]]
| location_country = {{USA}}
| location         = 
| locations        = 
| area_served      = 
| key_people       = 
| industry         = [[生物技术|生物技术]]
| products         = 
| services         = {{tsl|en|Drug discovery||Drug discovery}}
| revenue          = 
| subsid           = 
| homepage         = {{URL|http://insilicomedicine.com/}} 
| footnotes        = 
| intl             = 
}}
'''英科智能'''（{{lang-en|Insilico Medicine}}），是一家美國生物科技公司，總部座落於美國[[羅克維爾|羅克維爾]][[約翰霍普金斯大學|約翰霍普金斯大學]]新興科技中心。英科智能結合[[基因體學|基因體學]] 、[[大數據|大數據]]分析以及深度學習來進行電腦藥物開發。<ref>{{Cite web|url=https://www.eurekalert.org/pub_releases/2017-06/imi-iml053117.php|title=Insilico Medicine launches a drug discovery platform ALS.AI|accessdate=28 August 2017|language=en}}</ref><ref>{{Cite web|url=http://www.fiercebiotech.com/medtech/gsk-taps-baltimore-s-insilico-for-ai-based-drug-discovery|title=GlaxoSmithKline taps Baltimore’s Insilico for AI-based drug discovery {{!}} FierceBiotech|accessdate=28 August 2017|language=en}}</ref><ref>{{Cite web|url=https://pitchbook.com/profiles/insilico-medicine-profile-investors-funding-valuation-and-analysis|title=InSilico Medicine Company Profile {{!}} PitchBook|accessdate=28 August 2017|language=en}}</ref>

== 歷史 ==
執行長亞歷克斯-扎沃洛科夫(Alex Zhavoronkov)於2014年創立英科智能，致力於發展替代方案來取代藥廠裡藥物研發中的[[動物實驗|動物實驗]]。藉由人工智慧以及深度學習技術，英科智能的AI引擎能夠分析藥物如何作用於細胞以及可能的副作用。透過Pharma.AI，英科智能提供[[机器学习|機器學習]]的服務給數家知名藥廠、生物科技公司以及化妝品公司。<ref>{{Cite web|url=https://www.news-medical.net/news/20170801/New-partnership-uses-artificial-intelligence-methods-to-develop-solutions-for-preventing-early-aging.aspx|title=New partnership uses artificial intelligence methods to develop solutions for preventing early aging|accessdate=28 August 2017|date=1 August 2017|language=en}}</ref><ref>{{Cite web|url=http://www.digitaljournal.com/tech-and-science/science/artificial-intelligence-targets-human-age-reversal/article/499851|title=Can artificial intelligence aid human age-reversal?|accessdate=28 August 2017|date=12 August 2017}}</ref> 英科智能亦聞名於透過自行創建的分子線上[[黑客松|黑客松]]來招募所需人才。<ref>{{Cite web|url=http://molhack.com/|title=MolHack Hackathon|accessdate=10 August 2018}}</ref>

英科智能有許多的合作案應用次世代的人工智慧技術例如[[生成对抗网络|生成對抗網路]](GANs)和[[强化学习|強化學習]](RL)來產生具有理想特性的新穎分子結構。<ref>{{Cite web|url=http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00346|title=druGAN: An Advanced Generative Adversarial Autoencoder Model for de Novo Generation of New Molecules with Desired Molecular Properties in Silico|accessdate=12 September 2017|date=5 September 2017|last=Kadurin|first=Artur|pages=3098–3104|doi=10.1021/acs.molpharmaceut.7b00346}}</ref><ref>{{Cite web|url=https://www.forbes.com/sites/patrickcox/2017/03/14/heres-how-pharma-is-using-ai-deep-learning-to-cure-aging/#32cd1a3913fe|title=Here's How Pharma Is Using AI Deep Learning To Cure Aging|accessdate=12 September 2017|last=Cox|first=Patrick|language=en}}</ref>透過和美國哈佛大學教授Alan Aspuru-Guzik研究團隊合作，他們發表了更好的生成對抗性網路架構，結合[[生成对抗网络|生成對抗網路]]、[[强化学习|強化學習]]以及可微神經電腦(DNC)來產生新的分子結構。<ref>{{Cite journal|title=Reinforced Adversarial Neural Computer for                            Molecular Design|last=Putin|first=Evgeny|last2=Asadulaev|first2=Arip|date=15 May 2018|journal=Journal of Chemical Information and Modeling|issue=6|doi=10.1021/acs.jcim.7b00690|volume=58|pages=1194–1204|last3=Ivanenkov|first3=Yan|last4=Aladinskiy|first4=Vladimir|last5=Sanchez-Lengeling|first5=Benjamin|last6=Aspuru-Guzik|first6=Alán|last7=Zhavoronkov|first7=Alex}}</ref>

英科智能最近和11個不同的研究機構共同發表在自然通訊的論文提出iPANDA降維演算法, <ref>{{cite web|url=https://www.nature.com/articles/ncomms13427|title=In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development|accessdate=12 September 2017|date=16 November 2016|pages=ncomms13427|language=en|doi=10.1038/ncomms13427|last1=Ozerov|first1=Ivan V.|last2=Lezhnina|first2=Ksenia V.|last3=Izumchenko|first3=Evgeny|last4=Artemov|first4=Artem V.|last5=Medintsev|first5=Sergey|last6=Vanhaelen|first6=Quentin|last7=Aliper|first7=Alexander|last8=Vijg|first8=Jan|last9=Osipov|first9=Andreyan N.|last10=Labat|first10=Ivan|last11=West|first11=Michael D.|last12=Buzdin|first12=Anton|last13=Cantor|first13=Charles R.|last14=Nikolsky|first14=Yuri|last15=Borisov|first15=Nikolay|last16=Irincheeva|first16=Irina|last17=Khokhlovich|first17=Edward|last18=Sidransky|first18=David|last19=Camargo|first19=Miguel Luiz|last20=Zhavoronkov|first20=Alex|website=Nature Communications}}</ref> 此外英科智能也和生物科技公司以外的單位合作發表論文專注在組織多樣性以及反種族歧視。<ref>{{cite web|url=https://www.newscientist.com/article/2139984-ai-photo-check-exposes-scale-of-diversity-problem-at-top-firms/|title=AI photo check exposes scale of diversity problem at top firms|accessdate=12 September 2017|website=New Scientist}}</ref> 英科智能並和[[葛蘭素史克|葛蘭素史克]] <ref>{{cite web|url=http://cen.acs.org/articles/95/i34/GSK-amps-AI-Insilico-pact.html|title=GSK amps up AI with Insilico pact {{!}} August 28, 2017 Issue - Vol. 95 Issue 34 {{!}} Chemical & Engineering News|accessdate=12 September 2017|last1=Jarvis|first1=Lisa M.|website=cen.acs.org}}</ref> Bio Time，<ref>{{cite web|url=https://www.eurekalert.org/pub_releases/2016-07/imi-tfa070116.php|title=The first AI system for human embryonic state analysis is available for testing|accessdate=12 September 2017|language=en|website=EurekAlert!}}</ref> Juvenescence，<ref>{{cite web|url=https://www.eurekalert.org/pub_releases/2017-07/imi-fmd072617.php|title=First molecules discovered by next-generation artificial intelligence to be developed into drugs|accessdate=12 September 2017|language=en|website=EurekAlert!}}</ref> 和量子電腦公司 YMK Photonics是合作夥伴。<ref>{{cite web|url=https://technical.ly/baltimore/2016/11/22/insilico-medicine-quantum-computing/|title=Insilico Medicine's work on a ‘virtual human’ now has quantum computing behind it - Technical.ly Baltimore|accessdate=12 September 2017|date=22 November 2016|website=Technical.ly Baltimore}}</ref>

2017年，英科智能當選[輝達 輝達]（NVIDIA）五大“潛在最具社會影響力AI公司“之一, <ref>{{cite web|url=https://venturebeat.com/2017/04/23/nvidia-identifies-the-top-5-ai-startups-for-social-impact/|title=Nvidia identifies the top 5 AI startups for social impact|accessdate=28 August 2017|date=23 April 2017|website=VentureBeat}}</ref> 英科智能在比利時、俄羅斯和英國設有研發中心，並透過各個程式設計[[黑客松|黑客松]]比賽來聘僱人才。<ref>{{Cite web|url=https://corp.mail.ru/en/press/releases/10013/|title=AgeHack@MLBootCamp: The first Eurasian hackathon on AI for longevity to launch|accessdate=28 August 2017}}</ref> 至2017年為止，英科智能從投資者募資到$8.26百萬美金，其中包括Deep Knowledge Venture 、JHU A-Level Capital, <ref>{{Cite web|url=https://www.eurekalert.org/pub_releases/2017-06/imi-jaa062817.php|title=JHU alumni-run A-Level Capital to support AI-powered drug discovery at Insilico Medicine|accessdate=12 September 2017|language=en}}</ref>Jim Mellon, <ref>{{Cite web|url=https://pharmaphorum.com/news/billionaire-jim-mellon-invests-ai-project-tackle-ageing/|title=Billionaire Jim Mellon invests in anti-ageing research firm - Pharmaphorum|accessdate=12 September 2017|date=11 April 2017}}</ref>and Juvenescence。<ref>{{Cite web|url=https://futurism.com/ai-is-helping-this-anti-aging-startup-uncover-ways-for-you-to-live-a-longer-healthier-life/|title=AI Is Helping This Anti-Aging Startup Uncover Ways for You to Live a Longer, Healthier Life|accessdate=12 September 2017|date=2 August 2017}}</ref><ref>{{Cite web|url=http://www.outsourcing-pharma.com/Preclinical-Research/Insilico-and-Juvenescence-advancing-AI-discovered-molecules|title=Insilico, Juvenescence joint venture to develop AI-discovered molecules into new drugs|accessdate=28 August 2017}}</ref><ref>{{Cite web|url=https://technical.ly/baltimore/2017/07/28/insilico-medicine-juvenescence/|title=Insilico Medicine signs deal to advance use of AI in discovering new drugs - Technical.ly Baltimore|accessdate=28 August 2017|date=28 July 2017}}</ref><ref name="a">{{Cite web|url=http://www.baltimoresun.com/business/bs-bz-insilico-medicine-raise-20170223-story.html|title=Insilico Medicine raises $10 million|accessdate=28 August 2017|last=Gantz|first=Sarah}}</ref> 在2018年公佈的投資者包括[[药明康德|藥明康德]] (中國一家提供整合新藥研發服務平台的巨擎)、[[彼得·戴曼迪斯|Peter Diamandis]]的 BOLD Capital以及 Pavilion Capital。<ref name="mediumpost">{{cite web|url=https://medium.com/insilicomedicine/the-new-era-for-ai-powered-drug-discovery-and-longevity-biotechnology-begins-for-insilico-following-c93e6efab423|title=The new era for AI-powered drug discovery and longevity biotechnology begins for Insilico following…|accessdate=10 August 2018|date=11 June 2018|last1=Zhavoronkov|first1=Alex|website=Medium}}</ref>

== 参考文献 ==
{{Reflist}}

[[Category:药物发现公司|Category:药物发现公司]]
[[Category:美国生物技术公司|Category:美国生物技术公司]]
[[Category:2014年成立的公司|Category:2014年成立的公司]]